As a CDMO serving pharmaceutical and biotech companies, PolyPeptide must adhere to stringent product quality requirements and regulations to protect the safety of patients. The Group is committed to driving sustainability by embedding core principles of sustainable business practices, ethical conduct, and regulatory compliance into its operations and Enterprise Risk Management framework.
At PolyPeptide, material sustainability topics are anchored in our corporate strategy and daily operations, reflecting our commitment to long-term value creation and alignment with evolving regulatory requirements. PolyPeptide’s strategy builds on its multi-site network to strengthen its foundations and competitive advantages, with innovation in green chemistry playing an increasingly important role in sustainable peptide drug manufacturing.
For further information regarding PolyPeptide’s strategy, market and business model, see Strategy – PolyPeptide.
Find more about PolyPeptide’s sustainability efforts in the Sustainability Report 2025, published in the Annual Report 2025
Our material sustainability topics
PolyPeptide endorses the UN Agenda 2030 and considers the 17 SDGs as an important reference point for a sustainable future. In line with PolyPeptide’s prioritized material topic areas below, the Group has set its sight to contribute to seven relevant SDG goals.
As part of our commitment to sustainable and responsible business practices, PolyPeptide has embedded the Ten Principles of the United Nations Global Compact into strategies and operations, and committed to respecting human and labor rights, safeguarding the environment, and working against corruption in all its forms.
Climate change mitigation
From August 2025, PolyPeptide near-term Greenhouse Gas (GHG) reduction targets are approved by the Science Based Targets Initiatives (SBTi).
People
PolyPeptide depends on its employees to run its operations in line with GMP requirements and to develop its project and technology portfolio, and its organization. The Group operates in compliance with EHS regulations and upholds strict principles for a fair, inclusive, and respectful workplace that values safety and work-life balance.
Green chemistry
PolyPeptide depends on its employees to run its operations in line with GMP requirements and to develop its project and technology portfolio, and its organization. The Group operates in compliance with EHS regulations and upholds strict principles for a fair, inclusive, and respectful workplace that values safety and work-life balance.
Product responsibility
PolyPeptide’s mission is to help its customers develop products, secure regulatory approvals, and successfully launch and commercialize their products. Through its network of six GMP-certified manufacturing sites on three continents, PolyPeptide strives to meet customer requirements in terms of quality, quantity, and time.
Supply chain engagement
PolyPeptide relies on an international network of suppliers for goods and services. The Group actively seeks to work with its suppliers to ensure and promote sustainable business and responsible human rights practices within its supply chain. It has a Group-wide Supply Chain Policy on Child Labor that reinforces its commitment to complying with all applicable laws and regulations on Child Labor.
Business ethics and compliance
PolyPeptide is committed to ethical behavior and compliance with legal and regulatory requirements. This includes a secure digital environment to protect sensitive data and business information. It requires adherence to its Code of Business Conduct and Ethics, with procedures in place to identify potential wrongdoing and misbehavior.
Our certifications and ratings
The Group participates in the Carbon Disclosure program (CDP), scoring a “B” rating in 2025 (2024: B). This is complemented by the EcoVadis ratings, where PolyPeptide received an “Leader” rating for its carbon management program in 2026 and a “Gold” rating for its sustainability program, a recognition awarded to the Top 5% of companies assessed by EcoVadis in the 12 months prior to the medal issue date.
Since January 2026, all manufacturing sites are certified according to ISO45001:2018 Occupational health & safety, ISO14001:2015 Environmental management and ISO27001:2022 Information Security. PolyPeptide manufacturing site in Ambernath (India) is certified according to ISO50001: 2018 Energy management.
For more details about PolyPeptide’s sustainability efforts, please contact [email protected]
| ISO Certifications | |
PolyPeptide Group |
ISO27001 certificate |
| Ambernath, India | ISO45001 certificate ISO14001 certificate |
| Braine-l’Alleud, Belgium | ISO45001 certificate ISO14001 certificate |
| Malmö, Sweden | ISO45001 certificate ISO14001 certificate |
| Strasbourg, France | ISO45001 certificate ISO14001 certificate |
| USA | ISO45001 certificate ISO14001 certificate |